US Military contributions to the global response to pandemic chikungunya.

[1]  A. P. Adams,et al.  Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein , 2012, Journal of Virology.

[2]  A. Hawksworth,et al.  Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012. , 2012, MSMR.

[3]  E. Wang,et al.  Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism , 2011, PLoS pathogens.

[4]  S. Weaver,et al.  Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus. , 2011, The American journal of tropical medicine and hygiene.

[5]  S. Merler,et al.  Transmission Potential of Chikungunya Virus and Control Measures: The Case of Italy , 2011, PloS one.

[6]  S. Weaver,et al.  Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling. , 2011, Vaccine.

[7]  A. Suhrbier,et al.  A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. , 2011, Vaccine.

[8]  N. Sardesai,et al.  A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates , 2011, PLoS neglected tropical diseases.

[9]  Mary E. Wilson,et al.  Chikungunya fever: an epidemiological review of a re-emerging infectious disease. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Mohsin Khan,et al.  Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. , 2009, Vaccine.

[11]  K. Ezzedine,et al.  Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period , 2009, PLoS neglected tropical diseases.

[12]  D. Vaughn,et al.  Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military. , 2008, Military medicine.

[13]  S. Higgs,et al.  A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential , 2007, PLoS pathogens.

[14]  S. Larrieu,et al.  A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. , 2007, The American journal of tropical medicine and hygiene.

[15]  Alain Michault,et al.  Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Didier Raoult,et al.  Chikungunya outbreaks--the globalization of vectorborne diseases. , 2007, The New England journal of medicine.

[17]  E. Farnon.  Update: chikungunya fever diagnosed among international travelers--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.

[18]  M. Bangs,et al.  Tracking the re-emergence of epidemic chikungunya virus in Indonesia. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  S. Lemon,et al.  Protecting Our Forces , 2002 .

[20]  S. Lemon,et al.  Recommendations with Accompanying Analysis of Limitations Imposed by Current Department of Defense Structure for Managing Acquisition of Vaccines Against Infectious Diseases , 2002 .

[21]  C. Tacket,et al.  Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. , 2000, The American journal of tropical medicine and hygiene.

[22]  M. Diallo,et al.  Vectors of Chikungunya virus in Senegal: current data and transmission cycles. , 1999, The American journal of tropical medicine and hygiene.

[23]  C. Rossi,et al.  Immunologic interference from sequential administration of live attenuated alphavirus vaccines. , 1998, The Journal of infectious diseases.

[24]  R. Feigin,et al.  Textbook of Pediatric Infectious Diseases (Volume 1) , 1998 .

[25]  Turell Mj,et al.  Limited potential for mosquito transmission of a live, attenuated chikungunya virus vaccine. , 1992 .

[26]  P. Repik,et al.  Development of an attenuated strain of chikungunya virus for use in vaccine production. , 1986, Vaccine.

[27]  D. Burke,et al.  Disappearance of Chikungunya virus from Bangkok. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[28]  P. Bartelloni,et al.  Production and evaluation of a formalin-killed Chikungunya vaccine. , 1971, Journal of immunology.

[29]  F. Hetrick,et al.  Chikungunya virus vaccine prepared by Tween-ether extraction. , 1970, Applied microbiology.

[30]  L. Binn,et al.  Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues. , 1967, The American journal of tropical medicine and hygiene.